These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22699395)

  • 1. Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.
    Scicinski J; Oronsky B; Taylor M; Luo G; Musick T; Marini J; Adams CM; Fitch WL
    Drug Metab Dispos; 2012 Sep; 40(9):1810-6. PubMed ID: 22699395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of methods for the bioanalysis of RRx-001 and metabolites.
    Scicinski J; Oronsky B; Cooper V; Taylor M; Alexander M; Hadar R; Cosford R; Fleischmann T; Fitch WL
    Bioanalysis; 2014 Apr; 6(7):947-56. PubMed ID: 24806903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.
    Breda M; Benedetti MS; Battaglia R; Castelli MG; Poggesi I; Spinelli R; Hackett AM; Dostert P
    Pharmacol Res; 2000 Feb; 41(2):239-48. PubMed ID: 10623492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical disposition of GDC-0973 and prospective and retrospective analysis of human dose and efficacy predictions.
    Choo EF; Belvin M; Boggs J; Deng Y; Hoeflich KP; Ly J; Merchant M; Orr C; Plise E; Robarge K; Martini JF; Kassees R; Aoyama RG; Ramaiya A; Johnston SH
    Drug Metab Dispos; 2012 May; 40(5):919-27. PubMed ID: 22315332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
    Fukano Y; Kawazu K
    Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and disposition of moxonidine in Fischer 344 rats.
    He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
    Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of TAK-044, a new endothelin antagonist, in rats and dogs.
    Maeshiba Y; Takeuchi T; Kondo T; Yamashita K; Tsukuda R; Yoshimura Y
    Arzneimittelforschung; 2002; 52(8):587-92. PubMed ID: 12236045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.
    Patel DK; Woolley JL; Shcokcor JP; Johnson RL; Taylor LC; Sigel CW
    Drug Metab Dispos; 1991; 19(2):491-7. PubMed ID: 1676660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors.
    Oronsky B; Scicinski J; Cabrales P; Minchinton A
    Clin Epigenetics; 2016; 8():53. PubMed ID: 27175220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
    Cho YB; Kim KH; Kim DK
    Drug Metab Dispos; 1995 Nov; 23(11):1280-5. PubMed ID: 8591731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
    Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of bis(4-fluorobenzyl)trisulfide and its formation of hemoglobin adduct in rat erythrocytes.
    Pan H; Gu L; Sun S; Chen Z; Zhou H; Zeng S; Jiang H
    Drug Metab Dispos; 2013 May; 41(5):1082-93. PubMed ID: 23439662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.